{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T16:46:26Z","timestamp":1756572386422},"reference-count":23,"publisher":"Elsevier BV","issue":"30","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.vaccine.2012.04.074","type":"journal-article","created":{"date-parts":[[2012,5,2]],"date-time":"2012-05-02T16:47:41Z","timestamp":1335977261000},"page":"4476-4479","source":"Crossref","is-referenced-by-count":9,"title":["The yellow fever 17D vaccine and risk of malignant melanoma in the United States military"],"prefix":"10.1016","volume":"30","author":[{"given":"Meredith","family":"Hodges-Vazquez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James P.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hayley","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Garman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2012.04.074_bib0005","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1016\/j.ejca.2004.06.003","article-title":"Cutaneous malignant melanoma in Europe","volume":"40","author":"Vries","year":"2004","journal-title":"European Journal of Cancer"},{"key":"10.1016\/j.vaccine.2012.04.074_bib0010","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1080\/028418602753669508","article-title":"Trends in incidence of cutaneous malignant melanoma in a Swedish population, 1976 to 1994","volume":"41","author":"Mansson-Brahme","year":"2002","journal-title":"Acta Oncology"},{"key":"10.1016\/j.vaccine.2012.04.074_bib0015","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1002\/cncr.22126","article-title":"The incidence and mortality of cutaneous melanoma in Southern Germany: trends by anatomic site and pathologic characteristics, 1976 to 2003","volume":"107","author":"Lasithiotakis","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.vaccine.2012.04.074_bib0020","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s10227-003-0159-0","article-title":"Trends in invasive cutaneous melanoma in Saskatchewan 1970-1999","volume":"7","author":"Ulmer","year":"2003","journal-title":"Journal of Cutaneous Medicine and Surgery"},{"issue":"14","key":"10.1016\/j.vaccine.2012.04.074_bib0025","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1001\/jama.288.14.1719","article-title":"Melanoma incidence and mortality among US whites, 1969\u20131999","volume":"288","author":"Geller","year":"2002","journal-title":"Journal of the American Medical Association"},{"key":"10.1016\/j.vaccine.2012.04.074_bib0030","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1038\/jid.2008.423","article-title":"Increasing burden of melanoma in the United States","author":"Linos","year":"2009","journal-title":"Journal of Investigative Dermatology"},{"key":"10.1016\/j.vaccine.2012.04.074_bib0035","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.clindermatol.2008.09.001","article-title":"Melanoma and epidemiology trends","volume":"27","author":"Garbe","year":"2009","journal-title":"Clinics in Dermatology"},{"key":"10.1016\/j.vaccine.2012.04.074_bib0040","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1016\/S0959-8049(03)00625-7","article-title":"Impact of vaccinations and infectious diseases on the risk of melanoma\u2013evaluation of an EORTC case\u2013control study","volume":"39","author":"Krone","year":"2003","journal-title":"European Journal of Cancer"},{"key":"10.1016\/j.vaccine.2012.04.074_bib0045","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1046\/j.1523-1747.2002.00643.x","article-title":"Inverse association between melanoma and previous vaccinations against tuberculosis and smallpox: results of the FEBIM study","volume":"119","author":"Pfahlberg","year":"2002","journal-title":"Journal of Investigative Dermatology"},{"key":"10.1016\/j.vaccine.2012.04.074_bib0050","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ejca.2004.09.023","article-title":"Prior immunization of patients with malignant melanoma with vaccinia or BCG is associated with better survival. An European Organization for Research and Treatment of Cancer cohort study on 542 patients","volume":"41","author":"Kolmel","year":"2005","journal-title":"European Journal of Cancer"},{"key":"10.1016\/j.vaccine.2012.04.074_bib0055","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ejca.2004.08.010","article-title":"Protection against melanoma by vaccination with Bacille Calmette Guerin (BCG) and\/or vaccinia: an epidemiology-based hypothesis on the nature of a melanoma risk factor and its immunological control","volume":"41","author":"Krone","year":"2005","journal-title":"European Journal of Cancer"},{"key":"10.1016\/j.vaccine.2012.04.074_bib0060","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.vaccine.2008.10.076","article-title":"Does yellow fever 17D vaccine protect against melanoma?","volume":"27","author":"Mastrangelo","year":"2009","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2012.04.074_bib0065","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.2105\/AJPH.92.12.1900","article-title":"The Defense Medical Surveillance System and the Department of Defense serum repository: glimpses of the future of public health surveillance","volume":"92","author":"Rubertone","year":"2002","journal-title":"American Journal of Public Health"},{"issue":"9","key":"10.1016\/j.vaccine.2012.04.074_bib0070","first-page":"6","article-title":"Incident diagnoses of malignant melanoma, active components, U.S. Armed Forces, January 1998\u2013June 2008","volume":"15","author":"Armed Forces Health Surveillance Center","year":"2008","journal-title":"Medical Surveillance Monthly Report"},{"issue":"9","key":"10.1016\/j.vaccine.2012.04.074_bib0075","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1592\/phco.24.13.1105.38083","article-title":"Pharmacoepidemiology II: the nested case-control study \u2013 a novel approach in pharmacoepidemiologic research","volume":"24","author":"Etminan","year":"2004","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.vaccine.2012.04.074_bib0080","series-title":"Health Information for International Travel, 2008","author":"Centers for Disease Control and Prevention","year":"2008"},{"issue":"RR\u201315","key":"10.1016\/j.vaccine.2012.04.074_bib0085","first-page":"1","article-title":"General recommendation on immunization: recommendations of the Advisory Committee on Immunization Practice (ACIP)","volume":"51","author":"Centers for Disease Control and Prevention","year":"2006","journal-title":"MMWR. Recommendations and Reports"},{"issue":"6","key":"10.1016\/j.vaccine.2012.04.074_bib0090","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1158\/1055-9965.EPI-09-0041","article-title":"Cancer incidence in the U.S. military population: comparison with rates from the SEER Program","volume":"18","author":"Zhu","year":"2009","journal-title":"Cancer Epidemiology, Biomarkers & Prevention"},{"key":"10.1016\/j.vaccine.2012.04.074_bib0095","series-title":"Troops have higher rates of some cancers","author":"Kennedy","year":"2010"},{"key":"10.1016\/j.vaccine.2012.04.074_bib0100","series-title":"TB Elimination: BCG Vaccine","author":"Centers for Disease Control and Prevention","year":"2011"},{"key":"10.1016\/j.vaccine.2012.04.074_bib0105","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.jaci.2006.09.037","article-title":"Smallpox vaccines: past, present, and future","volume":"118","author":"Parrino","year":"2006","journal-title":"The Journal of Allergy and Clinical Immunology"},{"issue":"24","key":"10.1016\/j.vaccine.2012.04.074_bib0110","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1001\/jama.289.24.3278","article-title":"US Military smallpox vaccination program experience","volume":"289","author":"Grabenstein","year":"2003","journal-title":"Journal of the American Medical Association"},{"key":"10.1016\/j.vaccine.2012.04.074_bib0115","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1023\/A:1007658503740","article-title":"Is there a relationship between influenza vaccinations and risk of melanoma? A population-based case\u2013control study","volume":"16","author":"Mastrangelo","year":"2000","journal-title":"European Journal of Epidemiology"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12006202?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12006202?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,23]],"date-time":"2018-11-23T18:28:53Z","timestamp":1542997733000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X12006202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":23,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0264410X12006202"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.04.074","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}